Equities

Vivos Therapeutics Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
VVOS:NAQ

Vivos Therapeutics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.66
  • Today's Change-0.055 / -3.22%
  • Shares traded47.10k
  • 1 Year change-57.99%
  • Beta6.8916
Data delayed at least 15 minutes, as of Feb 11 2026 17:37 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

  • Revenue in USD (TTM)17.32m
  • Net income in USD-17.10m
  • Incorporated2020
  • Employees109.00
  • Location
    Vivos Therapeutics Inc7921 Southpark Plaza,, Suite 210LITTLETON 80120United StatesUSA
  • Fax+1 (302) 655-5049
  • Websitehttps://vivos.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PAVmed Inc29.00k-595.00k10.91m39.0029.6229.89--376.29-0.6822-0.68220.00051.550.0009--3.05743.594.17-115.648.14-8,726.29-520.69--4,931.04-3,891.34----0.2111--22.15--148.24--15.12--
SINTX Technologies Inc1.27m-16.56m11.09m20.00--2.56--8.74-6.93-6.930.58941.130.11211.345.5263,500.00-86.86-51.41-121.23-64.3452.0566.36-775.12-575.951.60-302.730.0143--9.9033.18-33.06--36.24--
Envoy Medical Inc208.00k-28.61m11.22m42.00------53.96-1.44-1.440.0103-0.32180.02370.501.794,952.38-247.90-------294.23---10,475.00--0.4582-14.86-----28.80--10.55------
Movano Inc500.00k-17.05m11.29m32.00------22.57-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
QHSLab Inc2.61m-386.75k11.39m4.00------4.36-0.0373-0.03730.1997-0.05421.4926.3812.80653,480.00-22.10-39.97---284.7966.3755.22-14.80-44.620.17140.30381.63--51.31--44.65------
REMSleep Holdings Inc12.27k-3.01m11.65m6.00--48.29--949.24-0.0019-0.00190.000010.00020.01930.8251.51---472.04-107.16-671.87-177.2194.87---24,509.54-1,456.221.73--0.2146---42.47--39.36--5.18--
BioNano Genomics Inc28.72m-38.59m11.91m98.00--0.2286--0.4146-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
BioRegenx Inc1.93m-18.93m12.50m5.00------6.48-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
Vicarious Surgical Inc0.00-53.59m14.16m123.00--0.8418-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
United Health Products Inc0.00-2.95m14.98m10.00---------0.0116-0.01160.00-0.01290.00----0.00-2,405.94-4,956.01-----------137,625.90---16.29--------23.69------
Trinity Biotech PLC (ADR)49.41m-35.91m16.07m401.00------0.3252-2.19-2.223.19-2.570.50941.523.48123,217.00-37.02-23.08-52.54-35.9733.8138.51-72.67-32.840.4083-1.731.79--8.31-7.4115.33---3.22--
Vivos Therapeutics Inc17.32m-17.10m16.14m109.00--5.58--0.932-1.88-1.881.930.30630.8449--13.38158,871.60-83.45-85.27-120.33-138.5155.7467.27-98.77-108.16----0.7785--8.915.7018.02--26.46--
Retractable Technologies Inc37.90m-6.68m19.76m221.00--0.258123.770.5213-0.223-0.2231.272.560.24921.864.43171,495.80-4.248.45-4.509.59-2.4238.19-17.0115.054.54--0.0126---24.19-4.59-67.29--17.90--
Milestone Scientific Inc8.93m-6.67m20.21m17.00--7.92--2.26-0.0823-0.08230.10990.03250.90840.489614.06525,265.90-67.82-48.29-122.68-62.1471.8665.25-74.66-81.560.5103-837.640.2518---12.190.602731.97--0.40--
Adagio Medical Holdings Inc137.00k-79.15m21.39m86.00------156.14-4.75-4.750.0087-0.08530.0020.75583.041,593.02-114.09---130.69---1,468.61---57,771.53--0.6798-4.931.07--100.67---105.09------
Jin Medical International Ltd22.83m1.79m21.92m269.0012.230.785211.110.96010.01150.01150.14580.17830.5093.264.1584,857.363.8510.686.3416.5135.7934.537.5513.921.90--0.36170.0018.572.9027.710.155496.27--
Data as of Feb 11 2026. Currency figures normalised to Vivos Therapeutics Inc's reporting currency: US Dollar USD

Institutional shareholders

9.46%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 2025273.33k3.04%
Connective Capital Management LLCas of 30 Sep 2025200.00k2.23%
Strategic Wealth Investment Group LLCas of 30 Sep 2025100.00k1.11%
Geode Capital Management LLCas of 30 Sep 202553.29k0.59%
B. Riley Wealth Advisors, Inc.as of 30 Sep 202543.53k0.48%
DRW Securities LLCas of 30 Sep 202541.47k0.46%
Commonwealth Equity Services LLCas of 30 Sep 202541.00k0.46%
Renaissance Technologies LLCas of 30 Sep 202539.28k0.44%
Vanguard Fiduciary Trust Co.as of 31 Dec 202530.83k0.34%
BlackRock Fund Advisorsas of 30 Sep 202527.82k0.31%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.